Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
30.59
+0.86 (2.88%)
Mar 14, 2025, 10:56 AM EDT - Market open
Viking Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
36
Market Cap
3.43B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
VKTX News
- 21 hours ago - Viking Therapeutics: No Buyout Needed Now - Seeking Alpha
- 1 day ago - Viking Therapeutics' new contract is a game changer. Here's how much money it could bring in. - Market Watch
- 2 days ago - Viking Therapeutics Is Ready For A Standalone Future - Seeking Alpha
- 2 days ago - Viking Therapeutics: Finally, Here Comes The Buying Opportunity (Upgrade) - Seeking Alpha
- 3 days ago - Viking Therapeutics Signs Broad Manufacturing Agreement With CordenPharma to Support Commercialization of VK2735 - PRNewsWire
- 3 days ago - Viking Therapeutics: Signs Of Insufficient Differentiation In Obesity Treatment (Rating Downgrade) - Seeking Alpha
- 7 days ago - Stock Picks From Seeking Alpha's February 2025 New Analysts - Seeking Alpha
- 9 days ago - Viking Therapeutics to Participate at Upcoming Investor Conferences - PRNewsWire